Yes Next DC is trading at a premium. Premium to what? Well earnings metrics aren't relevant at the moment so let's look at Price to Book value. P/Bk of Next DC is 1.4x (and Price/Tangible books value of 1.4x). This compares to a P/Bk of 4.2x for Equinix (and over 7x for Price/Tangible Book value for EQIX). So yes Next is trading at a premium to book value, but is still far cheaper than comps.
Fitting out capacity is capital intensive. But bringing forward that capex spend would be a positive in my view as it means that there is demand for that capacity (meaning that earnings are coming sooner rather than later). I doubt management would spent money on fitting out additional capacity only to have it lay idle for years on end. The only negative for shareholders I see in bringing forward capex is if a dilutive equity raising was required. Given the company has just raised $60m in debt a near term equity raising seems less likely IMO.
There is a huge amount of short interest in Next. I can understand if some investors don't believe the data centre story but to say Next is a sell when it is trading at a mild premium to book value and such a large discount to listed competitors just does not compute with me...
- Forums
- ASX - By Stock
- NXT
- Share Price Catalyst?
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

Share Price Catalyst?, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online